Testing effectiveness (Phase 2)Study completedNCT00247572
What this trial is testing
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
Who this might be right for
Attention Deficit Disorder With HyperactivityAmphetamine-Related DisordersSubstance-Related Disorders
New River Pharmaceuticals 12